spacer
home > pmps > spring 2018 > fight against counterfeit drugs
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Fight Against Counterfeit Drugs

Among the myriad of challenges faced by the pharmaceutical industry, the challenge of counterfeit drugs is probably the greatest. It not only causes tremendous revenue losses, but also negatively impacts a company’s reputation and brand image. Most importantly, the miseries inflicted by it on human life are simply incalculable.

Counterfeit drugs are not only threatening the confidence in healthcare professionals and health programmes, but they are also increasing the burden on healthcare systems, national medicine regulatory authorities, law enforcement, and criminal justice systems. According to industry estimates, counterfeit medicines sales are ranging from €150-€200 billion (US$163-$217 billion) per year (1). To counter this increasing threat, government bodies in most countries are devising more robust and strict regulations to control the genesis and proliferation of fake medicines. Track-and-trace, along with pharma product serialisation, is the next firm step towards winning this fight.

The Increasing Serialisation Trend

Serialisation entails encoding of each pharma product coming off a packaging line with a unique identification code that can be traced at each point throughout the supply chain. The unique identification code can be stored into an online database along with the other valuable information about the product, such as manufacturer and batch details, thus allowing for monitoring and tracing the journey of each product, from packaging line right up to the patient. Currently, serialisation regulations are at different phases of development in various countries. To match these country-specific deadlines, most of the global pharma companies need to be track-and-trace- and serialisation-ready.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Gaurav Mohite at ACG Inspection Systems has over six years of expertise in holistic track-andtrace solutions for the pharma industry. He was part of the complete trackand- trace implementation team across all the ACG implementation globally. Gaurav had completed his master’s for Jamnalal Bajaj Institute of Management Studies, India, in marketing and bachelor degree in engineering. At the early stage of his professional career, he had worked on vision inspection systems and track-and-trace applications as developer and business analyst throughout the industry. Gaurav is currently working as product manager and working for product marketing, strategy planning, and technologic innovations.
spacer
Gaurav Mohite
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

HATRIC-based identification of receptors for orphan ligands (small molecules)

HATRIC-LRC (Ligand Receptor Capture) enables now the identification of small molecule targets on the surface of living cells! Even primary cells!
More info >>

White Papers

galenIQ - The smart excipient

BENEO-Palatinit GmbH

galenIQ combines a multitude of outstanding characteristics and is suitable for a wide range of pharmaceutical applications. galenIQ can be used as more than just a bulk excipient. It also serves as an anti-caking agent, anti-humectant agent, stabilizer or oral care and taste agent to mention just a few additional functions.
More info >>

 
Industry Events

T3: Trials, Tech and Transformation

30-31 May 2018, Raleigh Convention Center, Raleigh, NC

T3 is back for 2018 to provide you with the latest updates and top tips from across the clinical trials landscape. Connecting leading experts, influencers and innovators from pharma, biotech, CROs, patient advocacy groups, academia and beyond, T3 is themeeting place for all stakeholders to voice their questions, connect with peers, and get direct feedback from an expert speaker line-up.And this year, we're in Raleigh.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement